title: Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium.
abstract: Mycoplasma genitalium is a significant sexually transmitted pathogen, causing up to 25% of cases of nongonococcal urethritis in men, and it is strongly associated with cervicitis and pelvic inflammatory disease in women. Currently, the usual first-line treatment is the macrolide antibiotic azithromycin, but an increasing incidence of treatment failure over the last 5 years suggests the emergence of antibiotic resistance. The mutations responsible for macrolide resistance have been found in the 23S rRNA gene in numerous M. genitalium populations. A second-line antibiotic, the fluoroquinolone moxifloxacin, was thought to be a reliable alternative when azithromycin began to fail, but recent studies have identified mutations that may confer fluoroquinolone resistance in the genes parC and gyrA. The aim of this study was to determine the prevalence of antibiotic resistance in M. genitalium in Sydney, Australia, by detecting relevant mutations in the 23S rRNA gene, parC, and gyrA. M. genitalium-positive DNA extracts of specimens, collected from patients attending sexual health clinics in Sydney, were tested by PCR amplification and DNA sequence alignment. The 186 specimens tested included 143 initial patient specimens and 43 second, or subsequent, specimens from 24 patients. We identified known macrolide resistance-associated mutations in the 23S rRNA gene in 43% of the initial patient samples and mutations potentially associated with fluoroquinolone resistance in parC or gyrA sequences in 15% of the initial patient samples. These findings support anecdotal clinical reports of azithromycin and moxifloxacin treatment failures in Sydney. Our results indicate that further surveillance is needed, and testing and treatment protocols for M. genitalium infections may need to be reviewed.
authors: Department of Biological Sciences, Macquarie University, North Ryde, NSW, Australia. ktag4715@uni.sydney.edu.au
authors: Kaitlin A
authors: KA
authors: Tagg
authors: Neisha J
authors: NJ
authors: Jeoffreys
authors: Deborah L
authors: DL
authors: Couldwell
authors: Jennifer A
authors: JA
authors: Donald
authors: Gwendolyn L
authors: GL
authors: Gilbert
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001315:Australia; D027081:DNA Gyrase / Q000235:genetics; D027101:DNA Topoisomerase IV / Q000235:genetics; D004269:DNA, Bacterial / Q000235:genetics; D024881:Drug Resistance, Bacterial; D005260:Female; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D018942:Macrolides / Q000494:pharmacology*; D008297:Male; D009154:Mutation; D045704:Mycoplasma genitalium / Q000187:drug effects* / Q000235:genetics*; D016133:Polymerase Chain Reaction; D015995:Prevalence; D012338:RNA, Ribosomal, 23S / Q000235:genetics; D012189:Retrospective Studies
chemical_list: D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D024841:Fluoroquinolones; D018942:Macrolides; D012338:RNA, Ribosomal, 23S; D027101:DNA Topoisomerase IV; D027081:DNA Gyrase
references: Lancet. 2002 Mar 2;359(9308):765-6
references: 11888591
references: BJOG. 2010 Feb;117(3):361-4
references: 20015303
references: Microbiol Mol Biol Rev. 1998 Dec;62(4):1094-156
references: 9841667
references: Clin Infect Dis. 2011 Jan 15;52(2):163-70
references: 21288838
references: Lancet. 1981 Jun 13;1(8233):1288-91
references: 6112607
references: Clin Microbiol Rev. 2011 Jul;24(3):498-514
references: 21734246
references: Int J STD AIDS. 2008 Oct;19(10):676-9
references: 18824619
references: Int J Antimicrob Agents. 2010 Sep;36(3):255-8
references: 20580532
references: J Urol. 2002 Mar;167(3):1210-7
references: 11832700
references: Sex Transm Dis. 2009 Oct;36(10):598-606
references: 19704398
references: Int J STD AIDS. 2010 May;21(5):337-41
references: 20498103
references: J Clin Microbiol. 2011 Apr;49(4):1695-6
references: 21346049
references: J Antimicrob Chemother. 2009 Sep;64(3):529-38
references: 19567408
references: Emerg Infect Dis. 2006 Jul;12(7):1149-52
references: 16836839
references: Clin Infect Dis. 2001 Apr 1;32(7):995-1003
references: 11264026
references: Antimicrob Agents Chemother. 1996 Feb;40(2):491-3
references: 8834907
references: Clin Infect Dis. 2008 Dec 15;47(12):1546-53
references: 18990060
references: Antimicrob Agents Chemother. 2003 Oct;47(10):3323-5
references: 14506049
references: Clin Microbiol Infect. 2008 Aug;14(8):801-5
references: 18727805
references: Science. 1995 Oct 20;270(5235):397-403
references: 7569993
references: J Infect Dis. 2006 Feb 1;193(3):336-45
references: 16388480
references: Sex Transm Infect. 2011 Mar;87(2):107-9
references: 21071566
references: Antimicrob Agents Chemother. 1990 Jun;34(6):1271-2
references: 2168148
references: Emerg Infect Dis. 2011 Jun;17(6):1148-50
references: 21749801
references: Sex Transm Infect. 2008 Feb;84(1):72-6
references: 17932127
references: Antimicrob Agents Chemother. 2005 Mar;49(3):1190-3
references: 15728924
references: J Infect Dis. 2001 Jan 15;183(2):269-276
references: 11120932
references: Sex Transm Dis. 1997 May;24(5):284-6
references: 9153738
references: PLoS One. 2008;3(11):e3618
references: 18978939
references: J Clin Microbiol. 2010 Oct;48(10):3624-7
references: 20720022
references: PLoS Pathog. 2011 May;7(5):e1001324
references: 21637847
references: Sex Transm Infect. 2011 Aug;87(5):412-4
references: 21653933
references: PLoS One. 2012;7(4):e35593
references: 22532861
references: Sex Transm Infect. 2003 Apr;79(2):154-6
references: 12690141
references: MMWR Recomm Rep. 2006 Aug 4;55(RR-11):1-94
references: 16888612
references: Am J Obstet Gynecol. 2012 Jun;206(6):476.e1-8
references: 22483084
references: Antimicrob Agents Chemother. 2001 Jan;45(1):1-12
references: 11120937
references: Antimicrob Agents Chemother. 2009 Nov;53(11):4938-9
references: 19738019